title: Prostate cancer outcomes: the three questions.
abstract: Enhanced survival and therapeutic choices for men with prostate cancer mandate the evaluation of the "quality of survival". An exciting series of local, national and international health outcome improvement initiatives offer the enticing prospect of assessing and improving this.
authors.affiliation: Leeds Teaching Hospitals NHS Trust, Leeds Institute of Cancer and Pathology, Leeds, UK. Electronic address: adam.glaser@leedsth.nhs.uk.
authors.forename: Adam W
authors.initials: AW
authors.lastname: Glaser
authors.affiliation: Faculty of Health Sciences, Southampton University, Southampton, UK; Macmillan Cancer Support, London, UK.
authors.forename: Jessica L
authors.initials: JL
authors.lastname: Corner
mesh_terms: D002755:Choice Behavior; D019033:Delivery of Health Care, Integrated / Q000592:standards*; D006801:Humans; D008297:Male; D010358:Patient Participation; D018579:Patient Selection; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D019984:Quality Indicators, Health Care / Q000592:standards*; D011788:Quality of Life; D016896:Treatment Outcome